Published in Helicobacter on June 01, 2003
Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol (2007) 1.57
Field defects in progression to gastrointestinal tract cancers. Cancer Lett (2007) 1.28
Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol (2005) 1.19
H pylori exist in the gallbladder mucosa of patients with chronic cholecystitis. World J Gastroenterol (2007) 0.99
H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci (2012) 0.96
Genetic aspects of gastric cancer instability. ScientificWorldJournal (2012) 0.92
Cell resilience in species life spans: a link to inflammation? Aging Cell (2010) 0.86
Spermine oxidase, a polyamine catabolic enzyme that links Helicobacter pylori CagA and gastric cancer risk. Gut Microbes (2012) 0.83
Relationship among oxidative DNA damage, gastric mucosal density and the relevance of cagA, vacA and iceA genotypes of Helicobacter pylori. Dig Dis Sci (2007) 0.79
Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike. World J Gastrointest Oncol (2016) 0.79
The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model. Dig Dis Sci (2004) 0.79
Gallstones and Concomitant Gastric Helicobacter pylori Infection. Gastroenterol Res Pract (2013) 0.77
HOGG1 polymorphism in atrophic gastritis and gastric cancer after Helicobacter pylori eradication. World J Gastroenterol (2010) 0.76
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol (2009) 3.29
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology (2004) 2.70
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell (2005) 2.66
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology (2008) 2.63
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol (2008) 2.36
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol (2008) 2.32
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother (2011) 2.16
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis (2004) 1.66
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine (2004) 1.65
Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol (2008) 1.62
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clin Gastroenterol Hepatol (2010) 1.58
Barrett's epithelium after antireflux surgery. J Gastrointest Surg (2005) 1.52
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51
Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc (2007) 1.51
Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg (2015) 1.50
Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol (2006) 1.46
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics (2013) 1.39
Staging gastritis: an international proposal. Gastroenterology (2005) 1.29
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch (2011) 1.28
MicroRNA expression profiling of male breast cancer. Breast Cancer Res (2009) 1.22
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol (Oxf) (2007) 1.20
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl (2009) 1.18
MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer (2011) 1.17
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer (2008) 1.16
Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol (2013) 1.15
The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation. J Biol Chem (2013) 1.14
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma. PLoS One (2012) 1.12
Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol (2003) 1.12
Neck emergency due to parathyroid adenoma bleeding: a case report. J Med Case Rep (2009) 1.10
Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer (2012) 1.07
The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol (2006) 1.07
Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery (2010) 1.07
Hepatoid adenocarcinoma of the colon: what should we target? Pathol Oncol Res (2011) 1.05
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev (2008) 1.02
Gastritis: the histology report. Dig Liver Dis (2011) 1.02
Programmed cell death 4 protein in esophageal cancer. Oncol Rep (2010) 1.01
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol (2013) 1.00
Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis (2011) 0.99
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem (2008) 0.99
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology (2012) 0.98
Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm Bowel Dis (2004) 0.97
The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Invest (2013) 0.96
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology (2011) 0.96
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid (2011) 0.96
MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid (2012) 0.96
Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol (2013) 0.96
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur J Endocrinol (2011) 0.95
Anterior gradient 2 overexpression in lung adenocarcinoma. Appl Immunohistochem Mol Morphol (2012) 0.95
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood (2011) 0.94
Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res (2006) 0.94
PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch (2012) 0.93
Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol (2011) 0.93
Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma. Acta Otolaryngol (2009) 0.92
Hepatic spleen nodules (HSN). Scand J Gastroenterol (2010) 0.92
Pathogenesis of Helicobacter pylori infection. Helicobacter (2012) 0.92
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int J Cancer (2008) 0.91
Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma. BMC Gastroenterol (2012) 0.91
Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol (2004) 0.91
Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia. Am J Surg Pathol (2004) 0.91
microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut (2012) 0.91
Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol (2006) 0.91
Granular cell tumor of the intrapancreatic common bile duct: one case report and review of the literature. Ultrastruct Pathol (2004) 0.90
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters. Scand J Gastroenterol (2007) 0.89
BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability. Eur J Endocrinol (2010) 0.89
Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci (2006) 0.89
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol (2010) 0.88
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol (2013) 0.88
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy. Oncotarget (2013) 0.88
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect (2013) 0.88
CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res (2009) 0.88
Diffuse intra-abdominal clear cell myomelanocytic tumor: report of an unusual presentation of "PEComatosis" simulating peritoneal mesothelioma. Ann Diagn Pathol (2006) 0.87
Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol (2010) 0.86
Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control (2013) 0.86
miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol (2011) 0.86
Oxidative stress and inducible nitric oxide synthase induction in carcinogenesis. Dig Dis (2010) 0.86
Primary squamous cell carcinoma of the thyroid: immunohistochemical profile and literature review. Tumori (2007) 0.86
Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol (2012) 0.86
5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis. World J Gastroenterol (2013) 0.85
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. Virchows Arch (2014) 0.85
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey. World J Gastroenterol (2006) 0.85
5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results. Arch Med Res (2006) 0.85
Role of genotyping in non-small cell lung cancer treatment: current status. Drugs (2011) 0.84
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. Hum Pathol (2012) 0.84
Comparison of the diagnostic accuracy of combined elastosonography and BRAF analysis vs cytology and ultrasonography for thyroid nodule suspected of malignancy. Clin Endocrinol (Oxf) (2012) 0.84
Trifluoroacetylated proteins in liver and plasma of guinea pigs treated with HCFC-123 and halothane. Toxicol Lett (2003) 0.84
Microsatellite instability and hMLH1 and hMSH2 expression in renal tumors. Oncol Rep (2010) 0.84
Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. J Lab Clin Med (2003) 0.84
OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol (2008) 0.83